Long-term in vivo degradation behavior and near-implant distribution of resorbed elements for magnesium alloys WZ21 and ZX50  by Amerstorfer, F. et al.
Acta Biomaterialia 42 (2016) 440–450Contents lists available at ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /ac tabiomatFull length articleLong-term in vivo degradation behavior and near-implant distribution
of resorbed elements for magnesium alloys WZ21 and ZX50http://dx.doi.org/10.1016/j.actbio.2016.06.025
1742-7061/ 2016 Acta Materialia Inc. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author at: Department of Orthopedics and Orthopedic Surgery,
Medical University Graz, Auenbruggerplatz 5, 8036 Graz, Austria.
E-mail address: anneliemartina.weinberg@medunigraz.at (A.M. Weinberg).F. Amerstorfer a, S.F. Fischerauer b, L. Fischer c, J. Eichler a, J. Draxler d, A. Zitek d, M. Meischel e, E. Martinelli a,
T. Kraus f, S. Hann c, S.E. Stanzl-Tschegg e, P.J. Uggowitzer g, J.F. Löffler g, A.M. Weinberg a,⇑, T. Prohaska d
aDepartment of Orthopedic and Orthopedic Surgery, Medical University of Graz, 8036 Graz, Austria
bDepartment of Trauma Surgery, Medical University of Graz, 8036 Graz, Austria
cUniversity of Natural Resources and Life Sciences, Department of Chemistry, Division of Analytical Chemistry – IACM Laboratory, 1190 Vienna, Austria
dUniversity of Natural Resources and Life Sciences, Department of Chemistry, Division of Analytical Chemistry – VIRIS Laboratory, 3430 Tulln, Austria
eDepartment of Material Sciences and Process Engineering, Institute of Physics and Materials Science, University of Natural Resources and Life Sciences, 1190 Vienna, Austria
fDepartment of Pediatric Orthopedics, Medical University of Graz, 8036 Graz, Austria
g Laboratory of Metal Physics and Technology, Department of Materials, ETH Zurich, 8093 Zurich, Switzerlanda r t i c l e i n f o
Article history:
Received 5 May 2016
Accepted 17 June 2016
Available online 22 June 2016
Keywords:
Magnesium
Alloy
Yttrium
Long-term
Degradation
Distributiona b s t r a c t
We report on the long-term effects of degrading magnesium implants on bone tissue in a growing rat
skeleton using continuous in vivo micro-Computed Tomography, histological staining and Laser
Ablation Inductively Coupled Plasma Mass Spectrometry (LA-ICP-MS). Two different magnesium
alloys—one rapidly degrading (ZX50) and one slowly degrading (WZ21)—were used to evaluate the bone
response and distribution of released Mg and Y ions in the femur of male Sprague-Dawley rats. Regardless
of whether the alloy degrades rapidly or slowly, we found that bone recovers restitutio ad integrum after
complete degradation of the magnesium implant. The degradation of the Mg alloys generates a significant
increase in Mg concentration in the cortical bone near the remaining implant parts, but the Mg accumu-
lation disappears after the implant degrades completely. The degradation of the Y-containing alloy WZ21
leads to Y enrichment in adjacent bone tissues and in newly formed bone inside the medullary space.
Locally high Y concentrations suggest migration not only of Y ions but also of Y-containing intermetallic
particles. However, after the full degradation of the implant the Y-enrichment disappears almost com-
pletely. Hydrogen gas formation and ion release during implant degradation did not harm bone regener-
ation in our samples.
Statement of Significance
Magnesium is generally considered to be one of the most attractive base materials for biodegradable
implants, and many magnesium alloys have been optimized to adjust implant degradation. Delayed
degradation, however, generates prolonged presence in the organism with the risk of foreign body reac-
tions. While most studies so far have only ranged from several weeks up to 12 months, the present study
provides data for complete implant degradation and bone regeneration until 24 months, for two magne-
sium alloys (ZX50, WZ21) with different degradation characteristics. lCT monitoring, histological stain-
ing and LA-ICP-MS illustrate the distribution of the elements in the neighboring bony tissues during
implant degradation, and reveal in particular high concentrations of the rare-earth element Yttrium.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. This is an open access article under the CCBY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Magnesium has long been considered as one of the most attrac-
tive biodegradable materials, because it occurs as a natural (trace)element in the human body [1]. It is involved in many metabolic
reactions and biological mechanisms [2] and can be easily excreted
through the urinary tract [3,4]. When implanted as a medical
device, magnesium reveals adequate biological response [3,5]
and demonstrates excellent properties for fracture stabilization,
as its elastic modulus occurs to be similar to that of human bone
[6]. Magnesium also shows stimulatory effects on the growth of
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feature of Mg-implants is, however, their ability to completely
degrade in a living organism, which would render an additional
surgery for implant removal in many clinical cases unnecessary
[5,6,12–14]. However, the corrosion process of magnesium in
physiological environment (pH at 7.4–7.6, high ion content, pres-
ence of proteins) is fairly rapid and is accompanied by the forma-
tion of hydrogen gas, which can cause tissue irritation and
reduce mechanical integrity [6,10,13,15,16]. The degradation per-
formance of a magnesium implant should therefore be balanced
with the bone’s healing process to provide sufficient primary frac-
ture stabilization and prevent malunion or refracture at later
stages. Hence, mechanical implant integrity over a time scale of
at least 3 months in adults [17,18] and 1.5 months in children is
essential.
For this purpose, various magnesium alloys have been tailored
with the aim of optimizing degradation behavior by using appro-
priate alloying elements, surface modifications, coatings, or various
processing techniques [14,19–28]. However, delayed degradation
behavior involves prolonged implant presence in the organism
and an attendant risk of foreign body reactions. Because most
available studies cover observation periods from a few weeks to
only 12 months, information on long-term effects until full implant
degradation and beyond are still lacking. Additionally, rare-earth
elements (REEs) such as Yttrium (Y) have been used in many Mg
alloy designs to increase the strength, ductility, and corrosion
resistance of the metal [29,30]. The issue that arises with REEs,
however, is a lack of knowledge regarding their body clearance
and potential effects on the physiological system. A recent compar-
ative study by Rössig et al. in fact reported that REEs accumulate in
inner organs after implant degradation [31]. Further research into
the systemic and local long-term effects of REEs is needed to
enable precise statements about their suitability for clinical
implementation.
We have already reported on the in vivo degradation and bio-
logical response of REE-free versus Y-containing alloys (ZX50 and
WZ21) over a period of 9 months [5]. This follow-up study is the
first that specifically investigates the long-term biological response
until full material degradation and beyond (24 months in total).
We also report on the local distribution, bony incorporation, and
local clearance of Mg- and Y-ions during material degradation.Table 1
Nominal compositions in wt% and mechanical properties of alloys ZX50 and WZ21.
Alloy ZX 50 WZ 21
Nominal compositions (wt%)
Mg Balance Balance
Zn 5 1
Ca 0.25 0.25
Mn 0.15 0.15
Y – 2
Biomechanical characteristics
Yield stress 210 MPa 150 MPa
Ultimate tensile strength 295 MPa 250 MPa
Uniform elongation 18% 20%
Elongation at fracture 26% 28%2. Material and methods
2.1. Experimental design
Surgical treatment, lCT and histological examination were per-
formed in accordance with the preliminary study of Kraus et al. [5].
The animal experiments were performed with ethical respect for
animals and were ethically approved by the Austrian Ministry of
Science and Research (accreditation number BMWF-66.010/0113-
II/10b/2009). Male Sprague–Dawley rats with body weights of
140–160 g and age of 5 weeks were used. The animals were housed
in groups of four in clear plastic cages on standard bedding and
allowed water and a standard pellet diet ad libitum.
Thirty-eight rats were divided into two groups: the ‘‘continu
ous-lCT” group (n = 16) and the ‘‘histological” group (n = 22). Each
rat in these groups received two identical pins of either alloy WZ21
or alloy ZX50, which were implanted into the femoral bones.
The pins were dry-machined from extruded ZX50 and WZ21
profiles to cylindrical shapes of 8 mm length and 1.6 mm diameter.
After machining they were cleaned in a cascade of pure ethanol in
an ultrasonic bath and dried in warm air. Table 1 shows the nom-
inal compositions and the mechanical characteristics of ZX50 and
WZ21. A total of 76 pins were implanted.2.2. Micro-Computed Tomography
Continuous lCT and histological evaluations were performed at
months 9, 12, 15, 18 and 24 after surgery. A detailed description of
the lCT evaluation and histological examination was given by
Kraus et al. [5].
2.3. LA-ICP-MS
Laser Ablation Inductively Coupled Plasma Mass Spectrometry
(LA-ICP-MS) measurements were applied to investigate the newly
formed cortical bone area adjacent to WZ21 implants at 1, 9, 15,
and 24 months after implantation. The samples were explanted,
embedded in light-curing resin and cut through the central axis
of the implant analogously to the histologic examinations.
The resulting sections were investigated by LA-ICP-MS, using a
266 nm Nd:YAG Laser (CETAC LSX-200, Cetac, Omaha, Nebraska,
USA), which was operated at 100% energy level and 10 Hz repeti-
tion rate in lines parallel to the implant axis in defined increments.
The spot diameter of the laser was 50 lm and the scan speed was
set to 10 lm s1. The ablated material was transported via an
argon carrier gas flow of 1 L min1 directly into a quadrupole
ICP-MS (ELAN DRC-e, PerkinElmer, Waltham MA, USA), which
was operated in standard mode. Transient signals of 13C, 25Mg,
31P, 44Ca and 89Y were recorded during ablation. All signals were
corrected for the gas blank, which was recorded during one minute
prior to each measurement, resulting in a total of 90 data points.
This gas blank was also used to calculate the limits of detection
(LOD) for each individual isotope based on LOD = average + 3 r,
with r as the standard deviation of the measured gas blank signal
intensities. Subsequently, the average of the gas blank intensities
was subtracted from each individual value recorded during bone
ablation, and each individual value <LODwas set to zero. A moving
average of 5 values was used for further evaluation, producing a
spatial resolution in the scan direction of about 20 lm. To identify
the mineralized bone material, a threshold value considering the
Ca signal intensity and the carbon to phosphor ratio was deployed.
The threshold was set to Ca intensities of <10,000 cps and C/P
ratios of >0.03. These values are based on the measurement of pure
hydroxyapatite standards, a hydroxyapatite matrix of fresh bones
and NIST SRM 1486 (NIST, Gaithersburg MD, USA) bone reference
material. The threshold was applied in order to facilitate the quan-
tification of elements in mineralized bone structures by excluding
the areas of bone marrow, embedding material and the implanted
pin. The elemental mass fraction of Mg was quantified by using a
NIST SRM 1486 (NIST, Gaithersburg MD, USA) as standard after
normalization of the elemental signal to the 31P signal. Y was quan-
tified by using a doped HAP powder (Synthetic > 99.995%, Merck,
Darmstadt, Germany), which was pressed into a pellet for further
LA-ICP-MS measurements. Part of the pellet was dissolved in
HNO3/H2O2 (both p.a. quality, Merck) using microwave-assisted
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as internal standard as P is homogeneously distributed as con-
stituent of the mineralized bone material (hydroxyapatite). Ca
was not applied as a preferred internal normalization standard
because Mg can potentially substitute Ca during biodegradation
of the pin material. After data reduction, the transient signals were
converted and assigned to coordinates considering the laser scan
speed. The resulting chemical images were produced using ArcGIS
(Esri, Redlands, CA, USA). As a final step, mean values and standard
deviations of the Mg and Y mass fractions were calculated sepa-
rately for each line in the upper and lower cortical bone, and
expressed as relative changes to the respective basal levels. In
addition, the relative Ca/P ratio was calculated.3. Results
Eight rodents died from age-related weakness and pin disloca-
tion was observed in 5 femora. Thus fifty-five Mg pins remained
for long-term analysis. The presented lCT sections, histological
sections, and laser ablation images are representative examples
of the respective periods of in vivo investigation.
3.1. Degradation performance and biological response of ZX50
The degradation behavior of ZX50 during the first 9 months was
already reported by Kraus et al. [5]. After 4 months the ZX50 pins
showed full degradation and further bone remodeling occurred
during the follow-up observations.
In the present study, the medullary cavity showed almost full
remodeling after 9 months (see Fig. 1). Neither implant debris
nor corrosion products could be seen, and only small islets of
bony trabecula formation were present in the medullary cavity
(Fig. 2a–j). The enlarged stainings (Fig. 2b, d, f, h, j) showed
predominantly adipocytes in the medullary cavity and no
increased occurrence of inflammatory cells.
3.2. Degradation performance and biological response of WZ21
The degradation of the WZ21 pins was examined by in vivo lCT
from months 9 to 24 at intervals of 3 months until month 18. Fig. 3
shows the degradation behavior of the WZ21 implant as revealed
by continuous 2D lCT scans and 3D reconstructions. Intramedul-
lary pin sections degraded within 12 months, whereas cortical
implant parts remained in place for up to 18 months. Obviously,
the implant in the area of the cortical bone showed a delayed
degradation tendency compared to that in the medullary cavity.
Residuals of the implant at the site of the bone cortex were
observed up to 18 months (Fig. 3g). Full implant degradation
appeared at 24 months (Fig. 3i), as confirmed by qualitative lCT
and histological analysis (Fig. 4i). (Quantitative lCT analysis of
pin degradation was not possible due to the fact that the magne-
sium alloy could not always be clearly distinguished from the sur-
rounding bone.)
Fig. 4 illustrates the biological response on the basis of histolog-
ical stainings generated on explanted bone segments at 9, 12, 15,
18, and 24 months after implantation. Bone formation appeared
at the pin site during implant degradation (Fig. 4a–h), and cortical
bone was detected in direct adhesion to the implant without the
formation of a fibrous capsule (Fig. 4a, c, e, g). After full implant
degradation at 24 months no cortical defects remained, and only
tiny intramedullary islets of bony trabeculae were identified in
the medullary cavity, microscopically (Fig. 4i) and via 2-D lCT
scans (Fig. 3i).
Hydrogen gas bubbles were visible until 12 months after
implantation (Figs. 3a, c and 4a–d), which produced little areasof cell displacement around the implant (Fig. 4e, g). The repopula-
tion of these areas occurred mostly with adipocytes (Fig. 4e–j).
Compared to the preexisting intramedullary matrix the local cell
density in these regions was slightly lower, but the size of these
areas shrank continuously after full pin degradation (Fig. 4i).
No pathological increase in inflammatory cells—such as leuco-
cytes or plasma cells—in response to foreign objects was observed
in histological stainings over the whole examination period (Fig. 4f,
h, j).
3.3. Mg-distribution and Ca/P ratio
Fig. 5a–h illustrates the Mg mass fraction and Ca/P molar ratio
in the mineralized cortical bone relative to the basal level of the
respective bone. The LA-ICP-MS investigations were carried out
adjacent to the pin upon degradation of the WZ21 implant. During
the first months of pin degradation a significant increase in Mg was
observed in the cortical bone up to approximately 2–3 mm from
the pin boundary. An increase of the Mg mass fraction up to 50%
from the basal level was measured (Fig. 5a, b).
The increasing dissolution of the implant generated signifi-
cantly increased Mg concentrations in the cortical bone near the
remaining implant parts from months 9 to 15. Increased Mg mass
fractions of about one order of magnitude were observed in the
lower cortical bone area of one example (month 15; Fig. 5e, f),
where pin residuals were still present. In contrast, areas of fully
degraded implant parts—where re-mineralization had already
occurred—showed only slightly increased Mg levels (up to 20%)
(Fig. 5c–f). After 24 months the Mg concentrations of undisturbed
bone areas and in the area of newly formed bone at the former
implant site overlap within the measurement uncertainties and
show therefore no significant difference (Fig. 5g, h).
In the medullary bone area, no significant changes in the bone
could be observed. Even though similar increased levels of Mg
were observed close to the pin boundary, no significant Mg enrich-
ment was detected in the newly formed bone area.
In contrast to high Mg concentrations measured in the area
directly adjacent to the pin from the first months, the molar Ca/P
ratio of this area did not significantly differ from the ratio of undis-
turbed (basal) hydroxyapatite (Fig. 5b). Between 9 and 15 months
a steady decrease in the Ca/P ratio up to 20% was measured in the
adjacent pin areas (Fig. 5d, f). After 24 months the Ca/P ratios
showed no significant different molar ratios anymore throughout
the whole cortical bone in correspondence to apatite in the cancel-
lous bone (Fig. 5h). The cancellous bone material in the medullary
area also showed no distinct variation in the Ca/P ratio throughout
the whole degradation process.
3.4. Yttrium distribution
Fig. 6a–d depicts the Y mass fraction in the mineralized cortical
bone directly adjacent to the pin relative to the basal level (which
was about 100 ng g1). Even after just one month (Fig. 6a) the
degradation of the material resulted in an enrichment of Y in the
boundary region adjacent to the implant. Even though the Y con-
tent was still low compared to that observed during the subse-
quent degradation process, high variations in Y distribution
(regions of 10-fold differences in the concentration vs. regions with
basal Y levels) were already observed (reflected by the error bars in
Fig. 6a). After 9 months (Fig. 6b) the Y mass fraction in the cortical
bone showed a distinct increase at the pin boundary, with pro-
nounced variations in the Y mass fraction (reflected by the large
error bars). This phenomenon became even more pronounced as
the degradation process advanced. The Y concentration increased
locally by almost three orders of magnitude compared to the basal
level in the bone after 15 months (Fig. 6c), and the variation within
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Fig. 1. 2-D lCT slices (left) and 3-D lCT reconstructions (right) illustrating the long-term bone response (P9 months) of the ZX50 implants. The ZX50 implant degraded
completely within 4 months [5]. Intramedullar surrounding bony parts at the implant site are still detectable until month 12 (a,c), accompanying discrete remaining callus
formation at the cortical site (b,d). After 15 months, the bone has healed restitutio ad integrum (e–j).
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nitude. The large variations can be interpreted as migration of
metallic particles. However, after 24 months (Fig. 6d), when the
pin was fully degraded, the Y concentration had reached nearly
basal levels within the entire cortical bone area.
4. Discussion
The objective of this study was to evaluate the long-term degra-
dation behavior of Mg implants, and to examine the bone-implant
interface and the biological response until complete degradation of
the implant and beyond. Two Mg alloys were deployed: the quite
rapidly degrading REE-free alloy ZX50 and the slowly degrading
Y-containing alloy WZ21. After complete degradation the bones
recovered completely without remaining functional disturbances,independent of the material used. Using Laser Ablation Inductively
Coupled Plasma Mass Spectrometry (LA-ICP-MS)—a technique that
is preferred in chemical imaging of biological tissues such as bones
and teeth due to its high sensitivity, low detection limits, good
accuracy and precision [32–34]—we also paid special attention to
the local distribution and bony incorporation of Mg and Y ions dur-
ing implant degradation. Temporary incorporation of Mg and
Y into the cortical bone was detected, but also migration of
Y-containing intermetallic particles. The latter one is reflected by
the locally high Y values found during laser ablation.
The alloy ZX50 corroded very fast, reaching full degradation
within 4 months. Despite extensive ion release and hydrogen gas
formation during the first period of degradation [5], the bones
recovered very well. While after 12 months slight callus formation
could still be observed, the femurs healed restitutio ad integrum
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Fig. 2. Histological overview slides of ZX50 from months 9 to 24 (left-hand side) and enlarged recordings of the stainings (right-hand side, representing the respective red
boxes). The cortical bones show no defects (a,c,e,g,i). In the medullary cavity, only small islets of bony trabeculae were detectable (a–j). Adipocytes predominated the
medullary cavity. BT = bony trabecula, A = adipocytes, BM = bone marrow, > = preparation artifacts in the form of elongated areas and round particles.
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ZX50 during degradation are discussed below, together with a crit-
ical view on Mg-alloy WZ21.
WZ21 degraded with significant dependence on the surround-
ing environment: cortical pin parts remained much longer than
intramedullar implant sections. This phenomenon was first men-
tioned by Earl McBride in the late 1930 s, when he noticed that
Mg alloy plates and intramedullary pegs corroded faster than
intraosseous implants [35]. Similarly, Xu et al. reported that
MgMnZn alloys degrade more rapidly in the medullary cavity than
in cortical bone [36], and Gu et al. explored faster corrosion in the
distal femur than in the bone marrow cavity of the diaphyseal
region [37]. This may be caused by the close contact to blood ves-
sels and the rich supply of body fluids [37,38].
Mg ion release in combination with an increase in local pH val-
ues and Ca and P depositions are indications for the activation of
osteoblasts and osteocytes, generating macroscopically visible
new bone formations around the implant [10,13,39–41]. In accor-
dance with this, we observed newly formed bone around the
implant in the medullar cavity and new endosteal bone formation
overarching to the cortical bone. On the other hand, accelerated
intramedullary degradation of Mg led to unfavorable formation
of hydrogen gas due to the chemical reaction of Mg + 2H2O? Mg
(OH)2 + H2 [42]; demonstrated in detail by Kraus et al. [5]. The
water content and the local blood flow around the implant areconsidered the strongest determinants of local diffusion and solu-
bility of hydrogen in surrounding tissues [30,43]. In the slowly
degrading WZ21 quite small gas bubbles occurred during the
degradation process in the medullary cavity, suggesting that the
local hydrogen saturation of blood and tissues was exceeded at
some degradation steps. Consequently, small areas of total tissue
displacement in the vicinity of the degrading implant were
observed in histological stainings (Fig. 4e, g, i, j). In further stages,
refilling with cells occurred slowly but continuously. The long-
term observations of the biological response of ZX50 and WZ21
implants revealed no long-term deficits due to cell displacement,
even if a large amount of initial hydrogen gas release led to a tem-
porary disturbance of the bone structure within the first period
after pin implantation, as shown for alloy ZX50 by Kraus et al.
[5]. Nevertheless, for clinical application a low hydrogen gas
release is of importance, because the absorption ability of local tis-
sues is limited and extensive gas formation may affect fracture
consolidation.
The tolerance limits of Mg ion release are usually not exceeded
during Mg implant degradation. Gu et al. reported that even
at their fastest degradation rate Mg–Ca binary alloys
(DR  3 mg cm2 d1) could be considered for safe application,
because the daily amount of Mg release would be still at milligram
level and far below the daily allowance of Mg uptake (0.7 g d1)
[44–46]. For ZX50 the highest degradation rate was observed
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Fig. 3. 2-D lCT slices (left) and 3-D lCT reconstructions (right) illustrating the degradation process of bicortically inserted WZ21 implants and their bone response from
months 9–24. After 9 months, the pin still appears in cylindrical shape (a); after 12 months severe degradation in the medullary cavity is observed (c); simultaneous to the
degradation of the implant, new bone formation occurs at the pin site (c, e, g); after 24 months no pin material is detected and the bone shows full recovery (i). 3-D lCT
reconstructions show callus formation at the cortical bone (b, d, f, h) and complete realignment of the cortex after 24 months (j).
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between months 5 and 6 at 0.48 mg cm2 d1 [5]. Translated to
a clinical setting, a daily Mg release of 2.6 mg d1 and
1.5 mg d1, calculated for an intramedullary nail of 20 cm in
length and 4.5 mm in diameter (which, according to the biome-
chanical properties of Mg-alloys, represents an effective stabiliza-
tion method compared to the traditional usage of two titanium
or steel nails) would remain considerably below the recommended
daily uptake of a four-year-old child (130 mg d1) [47]. Homeo-
static control of serum Mg concentrations by the kidneys, as well
as variations in Mg serum concentrations due to Mg implant degra-
dation, have been disproved by many studies [3,10,37,48]. Besides
the kidneys, an additional homeostatic control is bone, which pro-
vides a reservoir of large concentrations of Mg to buffer acute
changes in serum Mg levels [48,49].In this study, during the first months of WZ21 degradation
LA-ICP-MS measurements revealed increased Mg concentration
in the mineralized matrix areas adjacent to the pin. Nevertheless,
the Ca/P molar ratio in the area of >1 mm corresponded to the ratio
in the basal cortical bone, indicating the same molar ratio as in
undisturbed hydroxyl apatite. At later stages when pin degradation
was well advanced (9 months), only slightly increased Mg levels of
up to 20% compared to those in the basal area appeared in the adja-
cent bone matrix. This indicates that most Mg ions were already
mobilized and not incorporated into the mineralized tissue. Most
areas still consisted of fully mineralized hydroxyapatite, as no dis-
tinct changes were noted in the Ca/P ratio. Only in the directly
adjacent pin area were noticeably increased Mg levels accompa-
nied by a slight decrease in the Ca/P ratio measured—which may
indicate the substitution of Ca by Mg at these sites. Increased Mg
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degradation areas at cortical sites—which can be understood by the
fact that blood flow and washout in these areas are diminished
(Fig. 5e). Reduced Ca/P levels in this area also indicate a re-
mineralization process where Ca was partially substituted by Mg.
At this stage it is unclear whether Ca substitution by Mg has an
effect on the mechanical stability of the bone matrix. However, full
regeneration and restoration of the bone matrix was observed after
complete pin degradation, underlined by the fact that neither Mg
enrichment nor inhomogeneous Mg/Ca and Ca/P ratios were
observed after 24 months.
Alloying of Y and other REEs is commonly used to improve the
mechanical properties and corrosion resistance of magnesium
alloys [24,50]. However, the toxicology and metabolic pathways
of Y and other REEs are still unclear. It has been reported that
Y3+ can bind to globulin and DNA [51], and uses transferrin as a
binding protein in blood plasma [52]. Inhaled Y or intravenouslyinjected YCl3 was found to be translocated to the skeleton and
taken up by phagocytes of the liver and spleen in rats [53,54].
The growth of mice was also suppressed when they received
5 ppm of Y3+ in their drinking water [55].
Before discussing the local distribution of Y around the degrad-
ing implant we will first consider the microstructure of WZ21, with
special emphasis on the Y distribution within the microstructure.
Fig. 7 shows a typical image of the microstructure, generated by
transmission electron microscopy [56]. Of particular interest is
the presence of relatively large (d  5 lm) intermetallic phases
(IMPs) of type Mg12YZn [56]. Obviously, some of the Y is not in
solid solution but consumed by the IMPs. Because the alloy was
extruded to rods at 380 C and afterwards rapidly cooled to room
temperature, we calculated the fraction of Mg12YZn and the
remaining Y content in the Mg matrix at this temperature using
the PANDAT algorithms with database PanMg_2013 [57]. This
resulted in 5.3 mol% Mg12YZn, with a Y content of 20 wt%, and
(a)
(c)
(e)
(g)
(b)
(d)
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(h)
Fig. 5. LA-ICP-MS measurements after 1, 9, 15 and 24 months: The left-hand side shows the resulting chemical images: nearly all of the pin remained after 1 month (a);
continual degradation of the pin after 9 and 15 months (c,e); full pin degradation at 24 months (g). The right-hand side (b,d,f,h) shows the Mg mass fraction (solid blue circles
for upper cortical bone, open blue circles for lower cortical bone) and the Ca/P ratio (solid red squares for upper cortical bone, open red squares for lower cortical bone)
relative to the basal level for the upper and lower cortical bone areas. Error bars represent standard deviations.
F. Amerstorfer et al. / Acta Biomaterialia 42 (2016) 440–450 4470.69 wt% Y in the matrix. Thus we can assume that only about 1/3
of the alloyed Y is in solid solution whereas the rest is incorporated
into intermetallic particles.Degradation of Mg alloys containing intermetallic particles is
assumed to take place via anodic dissolution of the Mg matrix,
releasing Mg ions and solute foreign atoms, in our case Y, and
(a) (b)
(c) (d)15 m
Fig. 6. LA-ICP-MS measurements after 1, 9, 15 and 24 months illustrating the Y mass fraction relative to the basal level for the upper (solid blue circles) and lower (open blue
circles) cortical bone areas (a–d). Error bars represent standard deviations.
Fig. 7. TEM micrograph of as-extruded WZ21 showing particles with ordered
arrays of stacking faults, typical of Mg12YZn (large arrows), and grain boundaries
decorated with small Mg2Ca intermetallic particles (small arrows). The black
regions correspond to holes in the TEM specimen [56].
448 F. Amerstorfer et al. / Acta Biomaterialia 42 (2016) 440–450leaving behind the more noble intermetallics, in our case Mg12YZn
[50]. The LA-ICP-MS results revealed a distinct increase in the Y
content at the pin boundary even at early stages of the degradation
process. With advanced degradation large amounts of Y occurred
not only at the pin boundary, but also further away in cortical bone
and newly formed bone inside the medullary space. As mentionedabove, two Y sources must be considered: Y in solid solution and Y
bound in Mg12YZn intermetallics. The locally very high concentra-
tions far away from the corroding pin may indicate migration not
only of released Y ions, but also of Mg12YZn particles. After com-
plete pin degradation and bone remodeling, however, no Y
remained locally in the bone matrix and the majority of Y seems
to be mobilized and evacuated.
According to Hirano and Suzuki [58] it is not clear which cells
within the bone take up most of the REEs, e.g. macrophages or ery-
throid cells. In any case their clearance from the bone is known to
be very slow [58]. In our study we observed areas of reduced cell
population at the former pin site, which may be due to former
gas formation and/or the delayed evacuation of Y-containing inter-
metallic particles. To verify a safe excretion of Y, further studies are
required to demonstrate the absence of systemic toxicity, for
example via organ pathology.
5. Conclusions
The long-term effects of two different magnesium alloys and
the corresponding bone response and local distribution of released
ions were investigated in a growing-rat model by continuous
in vivo l-CT monitoring and Laser Ablation Inductively Coupled
Plasma Mass Spectrometry (LA-ICP-MS). A rapidly degrading mag-
nesium alloy (ZX50) and a slowly degrading alloy (WZ21) were
tested. The following statements can be made:
 Bone recovers restitutio ad integrum after complete degradation
of the magnesium implant, in both the more slowly degrading
Y-containing alloy WZ21 and the rapidly degrading alloy
ZX50, where massive gas formation is temporarily observed.
F. Amerstorfer et al. / Acta Biomaterialia 42 (2016) 440–450 449 Degradation of the Mg alloy generates a significant increase in
Mg concentration in the cortical bone near the remaining
implant parts. After complete degradation, however, no differ-
ence in Mg content between undisturbed bone areas and newly
formed bone at the former implant site is seen.
 During degradation of alloy WZ21 large amounts of Y were
measured not only at the pin boundary, but also farer away in
cortical bone and in newly formed bone inside the medullary
space. The locally high Y concentrations suggest migration of
both Y ions and Y-containing intermetallic particles. After full
degradation of the implant Y-enrichment in bone tissues disap-
peared almost completely.
 It is recommended to verify a safe excretion of Y, for example by
organ pathology, to demonstrate the absence of systemic toxic-
ity for rare-earth-element containing biodegradable implants.Acknowledgements
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